Novel transcript, antisense to ACTR1A (ENSG00000273262)

This molecule is a **long noncoding RNA functioning as a natural antisense transcript** that is transcribed from the genomic region antiparallel to the ACTR1A gene. Natural antisense transcripts are widely found in mammalian genomes and can regulate gene expression of their sense (protein-coding) counterparts through mechanisms such as transcriptional interference, RNA masking, dsRNA-dependent pathways (including RNAi), and modulation of chromatin state. These transcripts generally do not encode proteins themselves and are not considered classical therapeutic targets (such as receptors, enzymes, or transporters). Their biological function is mainly in the fine-tuning of gene expression, rather than direct involvement in disease or drug response[1][2]. There is currently no evidence that this specific transcript, ENSG00000273262, is a direct disease driver, a drug target, or a biomarker. Further, as such antisense loci are often only computationally predicted with uncertain function and no established clinical relevance, it would be incorrect to treat this entity as a validated therapeutic or diagnostic target.

Other names

antisense to ACTR1AENSG00000273262

Transcriptional interference RNA masking dsRNA-dependent mechanisms (e.g., RNA interference) Chromatin remodeling[1][2]